Cogent Biosciences, Inc. (COGT)

Cogent Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	127.6	98.17	53.23	139.89	219.68	242.19
Short-Term Investments	110.25	188.91	212.48	119.39	-	-
Cash & Short-Term Investments	237.85	287.08	265.71	259.28	219.68	242.19
Cash Growth	-34.52%	8.04%	2.48%	18.02%	-9.29%	547.15%
Prepaid Expenses	7.16	9.4	5.06	4.44	2.95	2.72
Restricted Cash	-	-	-	1.26	-	-
Total Current Assets	245.01	296.47	270.77	264.97	222.63	244.91
Property, Plant & Equipment	24.95	26.56	30.34	31.1	4.48	4.75
Long-Term Investments	-	-	7.46	-	-	-
Other Long-Term Assets	4.86	4.86	4.86	4.75	4.98	1.26
Total Assets	274.82	327.9	313.44	300.81	232.09	250.92
Accounts Payable	16.63	12.01	10.66	5.84	3.48	0.73
Accrued Expenses	38.87	41.76	25.69	17.48	7.98	4.47
Current Portion of Leases	1.66	1.57	1.39	1.42	2.32	2.05
Other Current Liabilities	1.27	0.37	0.44	2.1	3.3	5.84
Total Current Liabilities	58.42	55.71	38.17	26.85	17.08	13.09
Long-Term Leases	15.05	15.9	17.47	18.23	0.83	3.16
Other Long-Term Liabilities	2.36	-	-	-	-	-
Total Liabilities	119.78	71.61	55.64	45.08	17.91	16.25
Common Stock	0.11	0.11	0.09	0.07	0.04	0.03
Additional Paid-In Capital	1,052	1,005	801.06	601.15	399.71	322.45
Retained Earnings	-1,005	-859.48	-603.62	-411.21	-270.97	-198.7
Comprehensive Income & Other	0.01	0.45	0.25	-0.1	-	-
Total Common Equity	47.12	145.69	197.77	189.91	128.78	123.79
Shareholders' Equity	155.04	256.29	257.8	255.74	214.18	234.67
Total Liabilities & Equity	274.82	327.9	313.44	300.81	232.09	250.92
Total Debt	60.66	17.47	18.85	19.65	3.16	5.21
Net Cash (Debt)	177.19	269.61	254.32	239.63	216.53	236.98
Net Cash Growth	-52.33%	6.01%	6.13%	10.67%	-8.63%	654.91%
Net Cash Per Share	1.57	2.59	3.19	4.07	5.59	21.39
Filing Date Shares Outstanding	139.78	110.54	103.91	69.95	45.81	37.19
Total Common Shares Outstanding	114	110.54	86.12	69.89	43.81	32.35
Working Capital	186.59	240.76	232.6	238.12	205.56	231.82
Book Value Per Share	0.41	1.32	2.30	2.72	2.94	3.83
Tangible Book Value	47.12	145.69	197.77	189.91	128.78	123.79
Tangible Book Value Per Share	0.41	1.32	2.30	2.72	2.94	3.83
Machinery	-	10.08	9.54	6.93	1.21	0.14
Construction In Progress	-	0.04	0.03	0.48	0.65	-
Leasehold Improvements	-	2.46	2.44	1.78	0.41	0.41

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q